| Dr Sonia Panchal, OD | |
|
2000 Route 38 # 1032, Cherry Hill, NJ 08002-2100 | |
| (856) 665-4111 | |
| Not Available |
| Full Name | Dr Sonia Panchal |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 2000 Route 38 # 1032, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841869005 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 27OA00705800 (New Jersey) | Primary |
| Provider Name | Charles M Cummins, Od, Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1598797722 PECOS PAC ID: 0446246995 Enrollment ID: O20040719000496 |
News Archive
Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.
In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy - delivered directly through a tumor's blood supply - is working.
Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.
A group of researchers from the Fat Institute (CSIC) and the University of Seville have confirmed that some wild plants have a high nutritional value. The scientists have found that several species of lupins from the mountains of Andalusia have a protein content similar to that of other cultivated legumes, as they publish in the online version of the Food Chemistry magazine.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sonia Panchal, OD 186 Douglas Ct, West Deptford, NJ 08086-2013 Ph: (856) 994-4042 | Dr Sonia Panchal, OD 2000 Route 38 # 1032, Cherry Hill, NJ 08002-2100 Ph: (856) 665-4111 |
News Archive
Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.
In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy - delivered directly through a tumor's blood supply - is working.
Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.
A group of researchers from the Fat Institute (CSIC) and the University of Seville have confirmed that some wild plants have a high nutritional value. The scientists have found that several species of lupins from the mountains of Andalusia have a protein content similar to that of other cultivated legumes, as they publish in the online version of the Food Chemistry magazine.
› Verified 5 days ago
Dr. Sofija Jenza, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2000 Nj-38, Suite 1735, Cherry Hill, NJ 08002 Phone: 646-798-6230 | |
Cherry Hill Eye Doctors, P.a. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2000 Route 38 Ste 1590, Cherry Hill, NJ 08002 Phone: 856-662-5656 Fax: 856-662-8975 | |
Abbate Family Eyecare, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2010 Marlton Pike W, Suite C, Cherry Hill, NJ 08002 Phone: 856-663-9494 Fax: 856-662-5451 | |
Dr. Louis R Iacoponi, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1301b N Kings Hwy, Cherry Hill, NJ 08034 Phone: 856-795-5656 | |
Dr. Charles H Fitzpatrick, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2432 Route 38, Cherry Hill, NJ 08002 Phone: 856-482-2933 Fax: 856-482-2936 | |
Soho Optical Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1720 Marlton Pike E, Soho Optical, Cherry Hill, NJ 08003 Phone: 856-874-0011 Fax: 856-874-0015 | |
Dr. Roslyn Handfinger Kushner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2010 Marlton Pike W Ste C, Cherry Hill, NJ 08002 Phone: 856-663-9494 |